{"id":6230,"date":"2018-07-23T16:41:47","date_gmt":"2018-07-23T20:41:47","guid":{"rendered":"https:\/\/www.silverlaw.com\/blog\/?p=6230"},"modified":"2018-07-23T16:41:47","modified_gmt":"2018-07-23T20:41:47","slug":"akers-bioscience-and-aegis","status":"publish","type":"post","link":"https:\/\/www.silverlaw.com\/blog\/akers-bioscience-and-aegis\/","title":{"rendered":"Akers Bioscience and Aegis"},"content":{"rendered":"

Akers Bioscience went public in 2014 using Aegis Financial as its investment banker and underwriter.\u00a0 In a subsequent offering in 2017, Akers investment banker and underwriter was Joseph Gunnar.<\/p>\n

Akers Bioscience develops, manufactures, and supplies rapid screening and testing products designed to deliver quicker and more cost-effective healthcare information to healthcare providers and consumers. The Company has advanced the science of diagnostics while responding to major shifts in healthcare through the development of several proprietary platform technologies. The Company’s state-of-the-art rapid diagnostic assays can be performed virtually anywhere in minutes when time is of the essence. The Company has aligned with major healthcare companies and high volume medical product distributors to maximize product offerings, and to be a major worldwide competitor in diagnostics.<\/p>\n

\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2017\/07\/Morgan-Stanley-broker-Peter-H.-Kim-Barred-for-Allegedly-Taking-Client-Funds-for-Personal-Use-300x200.jpg\"A class action lawsuit has been filed against Akers Biosciences, Inc. (“Akers” or the “Company”) (AKER) and certain of its officers. The class action, filed in United States District Court, District of New Jersey, and docketed under 18-cv-10805, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise, acquired Akers between May 15, 2017, through June 5, 2018, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.<\/p>\n

Continue reading \u203a<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

Akers Bioscience went public in 2014 using Aegis Financial as its investment banker and underwriter.\u00a0 In a subsequent offering in 2017, Akers investment banker and underwriter was Joseph Gunnar. Akers Bioscience develops, manufactures, and supplies rapid screening and testing products designed to deliver quicker and more cost-effective healthcare information to healthcare providers and consumers. The […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[602,590],"tags":[790,957,958,959],"class_list":["post-6230","post","type-post","status-publish","format-standard","hentry","category-class-action","category-misrepresentation-and-omission-of-material-facts","tag-aegis-financial","tag-akers-bioscience","tag-akers-bioscience-class-action","tag-scott-silver-akers-bioscience"],"yoast_head":"\nAkers Bioscience and Aegis — Securities Arbitration Lawyers Blog — July 23, 2018<\/title>\n<meta name=\"description\" content=\"Akers Bioscience went public in 2014 using Aegis Financial as its investment banker and underwriter.\u00a0 In a subsequent offering in 2017, Akers investment — July 23, 2018\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.silverlaw.com\/blog\/akers-bioscience-and-aegis\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Akers Bioscience and Aegis — Securities Arbitration Lawyers Blog — July 23, 2018\" \/>\n<meta name=\"twitter:description\" content=\"Akers Bioscience went public in 2014 using Aegis Financial as its investment banker and underwriter.\u00a0 In a subsequent offering in 2017, Akers investment — July 23, 2018\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2017\/07\/Morgan-Stanley-broker-Peter-H.-Kim-Barred-for-Allegedly-Taking-Client-Funds-for-Personal-Use.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Silver Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Akers Bioscience and Aegis — Securities Arbitration Lawyers Blog — July 23, 2018","description":"Akers Bioscience went public in 2014 using Aegis Financial as its investment banker and underwriter.\u00a0 In a subsequent offering in 2017, Akers investment — July 23, 2018","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.silverlaw.com\/blog\/akers-bioscience-and-aegis\/","twitter_card":"summary_large_image","twitter_title":"Akers Bioscience and Aegis — Securities Arbitration Lawyers Blog — July 23, 2018","twitter_description":"Akers Bioscience went public in 2014 using Aegis Financial as its investment banker and underwriter.\u00a0 In a subsequent offering in 2017, Akers investment — July 23, 2018","twitter_image":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2017\/07\/Morgan-Stanley-broker-Peter-H.-Kim-Barred-for-Allegedly-Taking-Client-Funds-for-Personal-Use.jpg","twitter_misc":{"Written by":"Silver Law Group","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.silverlaw.com\/blog\/akers-bioscience-and-aegis\/","url":"https:\/\/www.silverlaw.com\/blog\/akers-bioscience-and-aegis\/","name":"Akers Bioscience and Aegis — Securities Arbitration Lawyers Blog — July 23, 2018","isPartOf":{"@id":"https:\/\/www.silverlaw.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.silverlaw.com\/blog\/akers-bioscience-and-aegis\/#primaryimage"},"image":{"@id":"https:\/\/www.silverlaw.com\/blog\/akers-bioscience-and-aegis\/#primaryimage"},"thumbnailUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2017\/07\/Morgan-Stanley-broker-Peter-H.-Kim-Barred-for-Allegedly-Taking-Client-Funds-for-Personal-Use-300x200.jpg","datePublished":"2018-07-23T20:41:47+00:00","author":{"@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752"},"description":"Akers Bioscience went public in 2014 using Aegis Financial as its investment banker and underwriter.\u00a0 In a subsequent offering in 2017, Akers investment — July 23, 2018","breadcrumb":{"@id":"https:\/\/www.silverlaw.com\/blog\/akers-bioscience-and-aegis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.silverlaw.com\/blog\/akers-bioscience-and-aegis\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.silverlaw.com\/blog\/akers-bioscience-and-aegis\/#primaryimage","url":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2017\/07\/Morgan-Stanley-broker-Peter-H.-Kim-Barred-for-Allegedly-Taking-Client-Funds-for-Personal-Use.jpg","contentUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2017\/07\/Morgan-Stanley-broker-Peter-H.-Kim-Barred-for-Allegedly-Taking-Client-Funds-for-Personal-Use.jpg","width":3000,"height":2000},{"@type":"BreadcrumbList","@id":"https:\/\/www.silverlaw.com\/blog\/akers-bioscience-and-aegis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.silverlaw.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Akers Bioscience and Aegis"}]},{"@type":"WebSite","@id":"https:\/\/www.silverlaw.com\/blog\/#website","url":"https:\/\/www.silverlaw.com\/blog\/","name":"Securities Arbitration Lawyers Blog","description":"Published by Securities Arbitration Lawyers \u2014 Silver Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.silverlaw.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752","name":"Silver Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","caption":"Silver Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/6230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/comments?post=6230"}],"version-history":[{"count":1,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/6230\/revisions"}],"predecessor-version":[{"id":6231,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/6230\/revisions\/6231"}],"wp:attachment":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/media?parent=6230"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/categories?post=6230"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/tags?post=6230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}